J Masuyama

926 total citations
24 papers, 718 citations indexed

About

J Masuyama is a scholar working on Rheumatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J Masuyama has authored 24 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 6 papers in Epidemiology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J Masuyama's work include Systemic Lupus Erythematosus Research (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). J Masuyama is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). J Masuyama collaborates with scholars based in Japan and United States. J Masuyama's co-authors include Shogo Kano, Nagahiro Minato, Taku Yoshio, Seiji Minota, Chikao Morimoto, Jeffrey S. Berman, William W. Cruikshank, Akio Mimori, Makoto Furuse and Atsuya Takeda and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

J Masuyama

24 papers receiving 708 citations

Peers

J Masuyama
Comparison fields: 5 of 70
  • Rheumatology 260
  • Immunology 237
  • Immunology and Allergy 152
  • Pulmonary and Respiratory Medicine 113
  • Molecular Biology 94
Replace Yair Molad with:
Yair Molad Israel
Bonnie Mitchell United States
Elisabeth Peen Norway
Kimihiro Suzuki Japan
Hongyu Yang United States
P. A. Dyer United Kingdom
R B Clague United Kingdom
María‐Eugenia Miranda‐Carús Spain
Giovanni M. Frascà Italy
Ruth M. Tarzi United Kingdom
Yair Molad Israel View profile →
Citations per field, relative to J Masuyama
J Masuyama · 1×
Citations per year, relative to J Masuyama
J Masuyama · 1×

Countries citing papers authored by J Masuyama

Since Specialization
Citations

This map shows the geographic impact of J Masuyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Masuyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Masuyama more than expected).

Fields of papers citing papers by J Masuyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Masuyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Masuyama. The network helps show where J Masuyama may publish in the future.

Co-authorship network of co-authors of J Masuyama

This figure shows the co-authorship network connecting the top 25 collaborators of J Masuyama. A scholar is included among the top collaborators of J Masuyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Masuyama. J Masuyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
The molecular mechanisms of post-adhesive transmigration of T cells.
1
2 1
3 1
4 7
5
A novel cell surface antigen 4C8 for myeloid differentiation marker.
6
6 27
7
Association of interleukin 6 release from endothelial cells and pulmonary hypertension in SLE.
32
8 101
9 58
10
Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus.
43
11
[Progressive systemic sclerosis (PSS) and cancer--increasing coincidence rate of cancer in 67 PSS patients].
4
12
Long-term prognosis of patients with connective tissue disease accompanied by pulmonary hypertension: a retrospective study
1
13
Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
45
14
[Long-term retrospective study of patients with connective tissue diseases accompanied by pulmonary hypertension].
1
15 106
16
[A systemic lupus erythematosus patient with multiple aseptic bone necroses, thrombosis of superior mesenteric artery and anti-phospholipid antibody].
8
17
[A case of primary Sjögren's syndrome presenting as osteomalacia secondary to renal tubular acidosis].
7
18 159
19
[Effects of water purification on renal osteodystrophy in the patients with regular hemodialysis therapy].
1
20
A case of progressive systemic sclerosis complicated with polymyositis and Graves' disease.
9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026